PPT describes the potential of pharm market in India and its growth trajectory. The next growth would come from consumer healthcare and Bio similar Production. This PPT helps pharm student who are aspiring to join Industry but not sure about scope and potential.

1. INDUSTRY ORIENTATION PROGRAM 1

2. INDUSTRY ORIENTATION PROGRAM 2

3. INDUSTRY ORIENTATION PROGRAM 3

4. INDUSTRY ORIENTATION PROGRAM 4

5. INDUSTRY ORIENTATION PROGRAM 5
*Program consist of 5 modules
*Module 1– Introduction to Industry and Scope
*Module 2- Required Technical Competency
*Module 3- Required Behavioral competency
*Module 4- Preparation for Resume and Interview
*Module 5- Self Development Plan

6. INDUSTRY ORIENTATION PROGRAM 6
*
Introduction to Industry and
Scope

7. Science Based
Highly regulated
Quality & Patient Oriented (Not a profit oriented)
Direct & Indirect selling
Mfg. API, Drug products, Vaccines, Equipment's and
services (10 % in Vol)
USD 4.5 Billion (Pharmaceutical Industry 2011)
USD 18.5 Billion (Health care industry 2013)
Growth rate 19 – 20 %
Attracted 5 % FDI
Estimated to grow up to USD 22 Billion by 2015 & USD
32 billion by 2020
Health care could reach up to USD 55 Billion
250/8000 Mfg. units
18/ 38 R & D centers
INDUSTRY ORIENTATION PROGRAM 7

8. INDUSTRY ORIENTATION PROGRAM 8
*

9. INDUSTRY ORIENTATION PROGRAM 9

10. The National Skill Report 2013 prepared by CII
INDUSTRY ORIENTATION PROGRAM 10

11. INDUSTRY ORIENTATION PROGRAM 11

12. INDUSTRY ORIENTATION PROGRAM 12
*Hospital Chains
*Consumer Health care
*Biologics
*R & D
*Branded / Specialty products
Mfg.
*Branded Generics /Generics.
Manufacturing

13. INDUSTRY ORIENTATION PROGRAM 13
*
*The Rs 70,000 crore pharma industry is at a turning point where it
has pinned hopes on a booster dose from the government that could
get them back on track. Financial incentives, a push for R&D and
revival of bulk drugs are what the sector is eyeing. Lately, the only
excitement for pharma companies is the setting up of eight new
national investment and manufacturing zones (NIMZ) of a total of
16 announced by the previous government. Through such zones the
sector may get the much-needed API (active pharmaceutical
ingredients) manufacturing push, which has slackened owing to cost
competitiveness from China. The eight new NIMZs will be located at
Nagpur, Chittoor, Medak, Prakasam, Tumkur, Kolar, Bidar and
Gulbarga. “The government should now take measures that could
create an MIT (Massachusetts institute of Technology) in India where
there is a collaboration between universities, industry and
researchers,” said Satish Reddy, chairman of Dr Reddy’s.

14. INDUSTRY ORIENTATION PROGRAM 14
*Hospital pharmacy / Clinical Trials
*Biologics Mfg.
*Sales and Marketing of Specialty Products
*Consumer health care Mfg. and sales
*Manufacturing of Generic and Specialty products
Salary
20 k – 40 k

15. INDUSTRY ORIENTATION PROGRAM 15
Story of Drug Development

16. INDUSTRY ORIENTATION PROGRAM 16

17. INDUSTRY ORIENTATION PROGRAM 17

18. INDUSTRY ORIENTATION PROGRAM 18

19. INDUSTRY ORIENTATION PROGRAM 19